Glucose Biosensor Systems (Greater China) Holdings, Inc. Contracts & Agreements
108 Contracts & Agreements
- Business Finance (51 contracts)
- Business Operations (6)
- Human Resources (14)
- Intellectual Property (7)
- Uncategorized (30)
- DESCRIPTIONOF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 (Filed With SEC on September 18, 2024)
- At The Market Offering Agreement, dated September 18, 2024, by and between Intelligent Bio Solutions Inc. and Ladenburg Thalmann & Co. Inc (Filed With SEC on September 18, 2024)
- Form of Series H-1 Warrant (Filed With SEC on March 13, 2024)
- Form of Series H-2 Warrant (Filed With SEC on March 13, 2024)
- Form of Series I Pre-Funded Warrant (Filed With SEC on March 13, 2024)
- Form of Placement Agent Warrant (Filed With SEC on March 13, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on March 13, 2024)
- Registration Rights Agreement (Filed With SEC on March 13, 2024)
- Placement Agency Agreement (Filed With SEC on March 13, 2024)
- Consulting Agreement, dated February 29, 2024, by and between C2C Advisors Inc. and Intelligent Bio Solutions Inc (Filed With SEC on March 1, 2024)
- Form of Series G Warrant (Filed With SEC on February 7, 2024)
- Form of Placement Agent Warrant (Filed With SEC on February 7, 2024)
- Form of Warrant Inducement Agreement (Filed With SEC on February 7, 2024)
- Intelligent Bio Solutions Inc. 2019 Long Term Incentive Plan (as amended December 13, 2023) (Filed With SEC on December 14, 2023)
- Underwriting Agreement dated as of October 2, 2023, by and between Intelligent Bio Solutions Inc. and Ladenburg Thalmann & Co. Inc (Filed With SEC on October 4, 2023)
- Form of Series E Warrant (Filed With SEC on October 4, 2023)
- Form of Series F Warrant (Filed With SEC on October 4, 2023)
- Form of Representative Warrant (Filed With SEC on October 4, 2023)
- Warrant Agency Agreement, dated as of October 4, 2023, between Intelligent Bio Solutions Inc. and Continental Stock Transfer & Trust Company (Filed With SEC on October 4, 2023)
- Form of Underwriting Agreement between Intelligent Bio Solutions Inc. and Ladenburg Thalmann & Co. Inc (Filed With SEC on September 22, 2023)
- Form of Series E Warrant (Filed With SEC on September 22, 2023)
- Form of Series F Warrant (Filed With SEC on September 22, 2023)
- Form of Warrant Agency Agreement between Intelligent Bio Solutions Inc. and Continental Stock Transfer & Trust Company (Filed With SEC on September 22, 2023)
- Form of Leak-Out Agreement (Filed With SEC on September 22, 2023)
- Form of Voting Agreement (Filed With SEC on September 22, 2023)
- Form of Lock-Up Agreement (Filed With SEC on September 22, 2023)
- Form of Underwriting Agreement between Intelligent Bio Solutions Inc. and Ladenburg Thalmann & Co. Inc (Filed With SEC on September 11, 2023)
- Form of Series E Warrant (Filed With SEC on September 11, 2023)
- Form of Representative Warrant (Filed With SEC on September 11, 2023)
- Form of Warrant Agency Agreement between Intelligent Bio Solutions Inc. and Continental Stock Transfer & Trust Company (Filed With SEC on September 11, 2023)
- Form of Leak-Out Agreement (Filed With SEC on September 11, 2023)
- Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on August 23, 2023)
- Form of Convertible Loan Conversion Agreement (Filed With SEC on May 17, 2023)
- Intelligent Bio Solutions Inc. 2019 Long Term Incentive Plan (as amended May 8, 2023) (Filed With SEC on May 12, 2023)
- Underwriting Agreement, dated March 8, 2022, between Intelligent Bio Solutions Inc. and Ladenburg Thalmann & Co. Inc. as the representative of the several underwriters named... (Filed With SEC on March 10, 2023)
- Form of Representative Warrant (Filed With SEC on March 10, 2023)
- Form of Warrant (Filed With SEC on March 10, 2023)
- Form of Warrant Agency Agreement (Filed With SEC on March 10, 2023)
- Intelligent Bio Solutions Inc. 2019 Long Term Incentive Plan (as amended February 8, 2023) (Filed With SEC on February 9, 2023)
- Winx Capital Engagement Letter, dated December 16, 2022 (Filed With SEC on December 22, 2022)
- Form of Warrant (Filed With SEC on December 22, 2022)
- Form of Placement Agent Warrant (Filed With SEC on December 22, 2022)
- Form of Securities Purchase Agreement dated as of December 21, 2022 (Filed With SEC on December 22, 2022)
- Form of Registration Rights Agreement dated as of December 21, 2022 (Filed With SEC on December 22, 2022)
- Share Exchange Agreement, dated as of October 4, 2022, by and among (Filed With SEC on October 11, 2022)
- Investors Rights Agreement, dated as of October 4, 2022, by and among the Company, The Ma-Ran Foundation, The Gary W. Rollins Foundation and Jason Isenberg, as the RFA Sellers... (Filed With SEC on October 11, 2022)
- Registration Rights Agreement, dated as of October 4, 2022, by and among the Company and the stockholders of the Company named therein (Filed With SEC on October 11, 2022)
- Registration Rights Agreement, dated as of October 4, 2022, by and among the Company and the stockholders of the Company named therein (Filed With SEC on October 11, 2022)
- Voting Agreement, dated as of October 4, 2022, by and among the Company and the stockholders of the Company named therein (Filed With SEC on October 11, 2022)
- Form of Voting Agreement, dated as of October 4, 2022, by and among the Company, the Sellers Representatives named therein and each of Spiro Sakiris, Harry Simeonides and... (Filed With SEC on October 11, 2022)
- Extension Agreement, dated as of October 4, 2022, to Bridge Facility Agreement, dated as of June 16, 2022, between the Company and Intelligent Fingerprinting Limited (Filed With SEC on October 11, 2022)
- Deed of Amendment and Restatement, dated October 4, 2022, between Intelligent Fingerprinting Limited, Karin Briden and the Company (Filed With SEC on October 11, 2022)
- Deed of Amendment and Restatement, dated October 4, 2022, between Intelligent Fingerprinting Limited, Debra Coffey and the Company (Filed With SEC on October 11, 2022)
- Deed of Amendment and Restatement, dated October 4, 2022, between Intelligent Fingerprinting Limited, Thomas Johnson and the Company (Filed With SEC on October 11, 2022)
- Deed of Amendment and Restatement, dated October 4, 2022, between Intelligent Fingerprinting Limited, The Ma-Ran Foundation, The Gary W. Rollins Foundation and the Company (Filed With SEC on October 11, 2022)
- Deed of Amendment and Restatement, dated October 4, 2022, between Intelligent Fingerprinting Limited, John Polden and the Company (Filed With SEC on October 11, 2022)
- Deed of Amendment and Restatement, dated October 4, 2022, between Intelligent Fingerprinting Limited, Sennett Kirk III and the Company (Filed With SEC on October 11, 2022)
- Deed of Amendment and Restatement, dated October 4, 2022, between Intelligent Fingerprinting Limited, Sennett Kirk III Exempt Trust and the Company (Filed With SEC on October 11, 2022)
- Employment Agreement between the GBS (APAC) Pty Ltd and Steven Boyages (Filed With SEC on September 30, 2022)
- Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on September 22, 2022)
- Bridge Facility Agreement, dated as of June 16, 2022, between the Company and Intelligent Fingerprinting Limited (Filed With SEC on September 22, 2022)
- Employment Agreement between the Glucose Biosensor Systems (Greater China) Pty Ltd and Spiro Sakiris (Filed With SEC on September 15, 2022)
- Employment Agreement between the Glucose Biosensor Systems (Greater China) Pty Ltd and Harry Simeonidis (Filed With SEC on September 15, 2022)
- Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on September 16, 2021)
- Option Agreement (Filed With SEC on April 2, 2021)
- Form LSBD Warrant (Filed With SEC on December 21, 2020)
- Form of Exchange Agreement (Filed With SEC on December 21, 2020)
- Form of Registration Rights Agreement (Filed With SEC on December 21, 2020)
- Form of Purchase and Assignment Agreement (Filed With SEC on December 21, 2020)
- Form of Underwriters Warrant (Filed With SEC on December 8, 2020)
- Form LSBD Warrant (Filed With SEC on December 8, 2020)
- Form of Underwriters Warrant (Filed With SEC on November 16, 2020)
- Form of Underwriting Agreement (Filed With SEC on October 20, 2020)
- Form of Series A Warrant (Filed With SEC on October 20, 2020)
- Form of Series B Warrant (Filed With SEC on October 20, 2020)
- Form of Warrant Agency Agreement (Filed With SEC on October 20, 2020)
- Amended and Restated License Agreement between the Company and Life Science Biosensor Diagnostics Pty Ltd (Filed With SEC on October 13, 2020)
- Letter of Financial Assistance from The iQ Group Global Ltd (Filed With SEC on October 13, 2020)
- Letter of Financial Assistance from iQX Limited (Filed With SEC on October 13, 2020)
- Technology License Agreement between the Company and Life Science Biosensor Diagnostics Pty Ltd (Filed With SEC on October 13, 2020)
- Material Transfer Agreement between Life Science Biosensor Diagnostics Pty Ltd and Wyss Institute for Biologically Inspired Engineering (Filed With SEC on October 13, 2020)
- Amended and Restated License Agreement between the Company and Life Science Biosensor Diagnostics Pty Ltd (Filed With SEC on October 1, 2020)
- Letter of Financial Assistance from The iQ Group Global Ltd (Filed With SEC on October 1, 2020)
- Letter of Financial Assistance from iQX Limited (Filed With SEC on October 1, 2020)
- Technology License Agreement between the Company and Life Science Biosensor Diagnostics Pty Ltd (Filed With SEC on October 1, 2020)
- Material Transfer Agreement between Life Science Biosensor Diagnostics Pty Ltd and Wyss Institute for Biologically Inspired Engineering (Filed With SEC on October 1, 2020)
- Form of Employment Agreement between the Company and Mr. Simeonidis (Filed With SEC on August 6, 2020)
- Letter of Financial Assistance from The iQ Group Global Ltd (Filed With SEC on August 6, 2020)
- Letter of Financial Assistance from iQX Limited (Filed With SEC on August 6, 2020)
- Form of Letter of Equity Support from iQnovate Limited (Filed With SEC on August 6, 2020)
- Form of Letter of Equity Support from iQX Limited (Filed With SEC on August 6, 2020)
- Technology License Agreement between the Company and Life Science Biosensor Diagnostics Pty Ltd (Filed With SEC on August 6, 2020)
- Form of Letter of Equity Support from iQnovate Limited (Filed With SEC on November 29, 2019)
- Form of Letter of Equity Support from iQX Limited (Filed With SEC on November 29, 2019)
- Specimen Common Stock Certificate (Filed With SEC on September 19, 2019)
- Amended and Restated License Agreement between the Company and Life Science Biosensor Diagnostics Pty Ltd (Filed With SEC on September 19, 2019)
- Form of Employment Agreement between the Company and Mr. Simeonidis (Filed With SEC on August 21, 2019)
- Form of Employment Agreement between the Company and Mr. Sakiris (Filed With SEC on August 21, 2019)
- Form of Warrant (Filed With SEC on August 2, 2019)
- 2019 Incentive Equity Plan (Filed With SEC on August 2, 2019)
- Amended and Restated License Agreement between the Company and Life Science Biosensor Diagnostics Pty Ltd (Filed With SEC on August 2, 2019)
- Master Services Agreement between the Company and IQ3Corp Limited (Filed With SEC on August 2, 2019)
- Medical Affairs Services Agreement between the Company and Clinical Research Corporation (Filed With SEC on August 2, 2019)
- Form of Employment Agreement between the Company and Mr. Simeonidis (Filed With SEC on August 2, 2019)
- Form of Employment Agreement between the Company and Dr. Becker (Filed With SEC on August 2, 2019)
- Form of Employment Agreement between the Company and Mr. Sakiris (Filed With SEC on August 2, 2019)
- Letter of Financial Assistance from iQnovate Limited (Filed With SEC on August 2, 2019)
- Letter of Financial Assistance from iQX Limited (Filed With SEC on August 2, 2019)
